Harvard Bioscience (HBIO) FCF Margin (2010 - 2026)
Harvard Bioscience's (HBIO) quarterly FCF Margin came in at 5.24% in Q1 2026, down 1660.0% year-on-year from 0.34% in Q1 2025, and down 128.3% on a QoQ basis from 2.3% in Q4 2025.
Harvard Bioscience (HBIO) FCF Margin (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of FCF Margin data on file, last reported at 5.24% in Q1 2026.
- On a quarterly basis, FCF Margin fell 1660.0% year-over-year to 5.24% in Q1 2026; TTM through Mar 2026 was 2.23%, a 167.0% increase from a year earlier, with the FY2025 full-year figure at 6.32%, up 760.0% from the prior year.
- FCF Margin for Q1 2026 stood at 5.24%, down from 2.3% in the prior quarter.
- Over the last five years, FCF Margin for HBIO reached as high as 16.34% in Q3 2023 and fell as low as 8.54% in Q1 2022.
- Historically, FCF Margin has averaged 3.42% across 5 years, with a median of 4.26% in 2025.
- Across the five-year window, FCF Margin sank 2418 bps in 2024 and jumped 2024 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 8.6% in 2022, then soared by 43 bps to 12.34% in 2023, then slumped by 53 bps to 5.8% in 2024, then sank by 140 bps to 2.3% in 2025, then sank by 128 bps to 5.24% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 5.24% in Q1 2026, 2.3% in Q4 2025, and 4.26% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 20.74% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 37.88% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 11.58% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 4.30% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 36.36% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 9.26% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 8.91% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -13.60% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.56% |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | -5.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.24% |
| Dec 31, 2025 | -2.30% |
| Sep 30, 2025 | 4.26% |
| Jun 30, 2025 | 13.04% |
| Mar 31, 2025 | 11.36% |
| Dec 31, 2024 | 5.80% |
| Sep 30, 2024 | -7.84% |
| Jun 30, 2024 | -7.20% |
| Mar 31, 2024 | 3.09% |
| Dec 31, 2023 | 12.34% |
| Sep 30, 2023 | 16.34% |
| Jun 30, 2023 | 10.55% |
| Mar 31, 2023 | 5.30% |
| Dec 31, 2022 | 8.60% |
| Sep 30, 2022 | 0.77% |
| Jun 30, 2022 | -2.16% |
| Mar 31, 2022 | -8.54% |
| Dec 31, 2021 | -0.73% |
| Sep 30, 2021 | -3.84% |
| Jun 30, 2021 | 1.92% |